Home
Instituto Butantan

Instituto Butantan Market Share Analysis for August 2026

The Instituto Butantan is a Brazilian biologic research center located in Butantã, in the western part of the city of São Paulo, Brazil. Instituto Butantan is a public institution affiliated with the São Paulo State Secretariat of Health and considered one of the major scientific centers in the world.

Science and Education > Biology

Domainbutantan.gov.br

Year Founded1901

Employees1001 - 5000

Annual Revenue--

Instituto Butantan

Instituto Butantan (including company regionals)

butantan.gov.br

See more website traffic and engagement information

Total visits to Instituto Butantan's top domains

Understand Instituto Butantan market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

butantan.gov.br143.2K

See more with Sales Intelligence

Avg. visit duration in Instituto Butantan's top domains

Analyze Instituto Butantan engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

butantan.gov.br00:01:25

See more with Sales Intelligence

Avg. pageviews on Instituto Butantan's top domains

See how Instituto Butantan keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

butantan.gov.br2.49

See more with Sales Intelligence

Instituto Butantan top competitors by domain

Top similar sites in August 2026, ranked by their affinity

fiocruz.brCompany NameFiocruzEmployees1001 - 5000HQBrazil, BlumenauAnnual revenue$200M - $500MTotal visits1.7MScience and Education > Universities and Colleges

Top technologies used by Instituto Butantan

These are the website technologies, by industry, used by Instituto Butantan top domains

Advertising (5)

Google Adsense

Social (5)

Instagram

Conversion & Analytics (4)

Google Analytics

Audio Video Media (2)

YouTube

More Technologies

9

See all

News & Signals from Instituto Butantan

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsButantan is developing srRNA rabies vaccine in Latin America on Jun 19th '26.In addition to its tuberculosis program, Replicate has been awarded grants from the Gates Foundation to develop srRNA vaccine candidates for HIV and malaria, and has entered into a collaborative agreement with Instituto Butantan to develop and commercialize its srRNA rabies vaccine in Latin America.

NewsIasobio partners with Butantan.IAOSO Bio partners with Instituto Butantan to expand access to CAR-T cell therapy in Brazil.

NewsButantan is developing dengue vaccine.This approval is important because the facility is helping produce the dengue vaccine for Instituto Butantan, one of Brazil's leading public health institutions.